Evidence-based policies and new technologies may help the U.S. in the future of combating drug addiction.
View More The next frontier of combating drug addiction in America
Category: Healthcare
The past, present, and future of human challenge trials
Scientific, ethical, and regulatory considerations are key when designing human challenge trials.
View More The past, present, and future of human challenge trials
The future of treating aging
As our population ages, our medical institutions may need to re-evaluate the status quo.
View More The future of treating aging
Biogen’s Aduhelm controversy as a case study for accelerated approval biomarkers in Alzheimer’s and related diseases
The recent FDA Biogen controversy sheds light on the future of drug approval in America.
View More Biogen’s Aduhelm controversy as a case study for accelerated approval biomarkers in Alzheimer’s and related diseases
Biosecurity risks and governance in the age of synthetic biology
The rapid pace of biotechnology development poses real and alarming biosecurity risks.
View More Biosecurity risks and governance in the age of synthetic biology